Cost Benefit Evaluation of Cognate Drugs Prescribed for Medicaid Beneficiaries with Alzheimer’s Disease (AD) and Other Dementias

P.Murali Doraiswamy, K.Ranga Rama Krishnan, Ravi Anand, Hyesung Sohn, Jacquiline Danyluk, Richard D. Hartman, Jeffrey Veach, Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 26, pp. 705- 712 ,(2002) , 10.1016/S0278-5846(01)00326-8

Strahan Gw, An overview of nursing homes and their current residents: data from the 1995 National Nursing Home Survey. Advance data. pp. 1- 12 ,(1997)

A. F. Jorm, The epidemiology of Alzheimer's disease and related disorders Chapman and Hall. ,(1990)

Muhammad A. Shah, Jerzy Weigel, Maciej Bobinski, Henryk M. Wisniewski, Barry Reisberg, Emile Franssen, Clinical Diagnosis of Dementia: A Review John Wiley & Sons, Ltd. pp. 69- 141 ,(2003) , 10.1002/0470861878.CH2

Sebastian Schneeweiss, Philip S. Wang, Jerry Avorn, Robert J. Glynn, Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Services Research. ,vol. 38, pp. 1103- 1120 ,(2003) , 10.1111/1475-6773.00165

C. A. Cohen, D. P. Gold, K. I. Shulman, J. T. Wortley, G. McDonald, M. Wargon, Factors Determining the Decision To Institutionalize Dementing Individuals:A Prospective Study Gerontologist. ,vol. 33, pp. 714- 720 ,(1993) , 10.1093/GERONT/33.6.714

Alan Stevens, Jason Owen, David Roth, Olivio Clay, Alfred Bartolucci, William Haley, Predictors of Time to Nursing Home Placement in White and African American Individuals With Dementia Journal of Aging and Health. ,vol. 16, pp. 375- 397 ,(2004) , 10.1177/0898264304264206

Peter J. Whitehouse, Marian B. Patterson, Susie A. Sami, Quality of life in dementia: ten years later. Alzheimer Disease & Associated Disorders. ,vol. 17, pp. 199- 200 ,(2003) , 10.1097/00002093-200310000-00001

Richard Hartman, Yves Agid, Ravi Anand, Michael Rösler, Peter Dal-Bianco, Ana Cicin-Sain, Hannes B Stähelin, Marguirguis Gharabawi, Serge Gauthier, Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ. ,vol. 318, pp. 633- 640 ,(1999) , 10.1136/BMJ.318.7184.633

S. M. Albert, M. Sano, K. Marder, D. M. Jacobs, J. Brandt, M. Albert, Y. Stern, Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology. ,vol. 49, pp. 38- 43 ,(1997) , 10.1212/WNL.49.1.38